New Jersey

In Review: As expected, A 4953 has been scheduled for a hearing on Thursday, June 19 at 10:00 A.M. in the Assembly Financial Institutions and Insurance Committee. The agenda lists the bill as “Amendments Only,” meaning that a proposed committee amendment will be

In Review: PCMA received notice that the Assembly Insurance and Financial Institutions Committee intends to hold another hearing in mid-June regarding pharmacy benefit managers and the drug supply chain. The hearing will likely consider A 4953, the delinking Bill, again.

In Review: The Assembly Insurance and Financial Committee heard testimony from economists last week on the state of PBM reform. Notably, Committee Chair and sponsor of A4953 (delinking) Roy Freiman started the session informing the public that the committee plans

In Review: The Assembly Insurance and Financial Institutions Committee will hold a series of hearings beginning this Thursday on PBMs. The April 10 hearing will feature testimony from experts such as Rutgers University Law Professor Michael Carrier and Dr. Geoffrey Joyce,

In Review: PCMA met with New Jersey Assembly Speaker Craig Coughlin (D), AMO Deputy Executive Director Dan Harris, AMO Counsel Mark Iaconelli, and Adviser to the Speaker Stephan Lally about PCMA’s opposition to A. 4953, a delinking bill that also

In Review: Amendments to A 4953 were considered and ultimately adopted today in the Assembly Insurance and Financial Institutions committee. PCMA and Prime Therapeutics testified on the amendments and asked the committee to delay further consideration until after the 2023

In Review: New Jersey Families for Affordable Healthcare will launch its grassroots website and advertising campaign this week in response to A4953/S3842. The campaign will run for four weeks, with the exception of the Thanksgiving holiday week. PCMA has also

In Review: New Jersey has introduced a new PBM bill modeled on the federal “delinking” measure. The bill would, among other things, require compensation to a PBM to be on a flat fee basis, that PBMs have a fiduciary duty to

In Review: S 3703 (Vitale – D) has been introduced and requires any patient’s cost sharing amount be based on the final cost to the carrier. PCMA along with the states association of health plans has requested a meeting with

In Review: Senate Bill 3538 has been introduced and will require that Medicaid MCOs reimburse pharmacies at NADAC plus $10.92 and give the state auditor the right to audit pharmacy pricing practices to determine potential savings for the state. If